Bioventus Inc.BVSNASDAQ
Loading
Operating cash flow minus capital expenditures
5Y CAGR
+7.1%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $72.11M | +90.8% |
| 2024 | $37.79M | +373.4% |
| 2023 | $7.98M | +153.2% |
| 2022 | $-15.02M | -814.7% |
| 2021 | $2.10M | -95.9% |
| 2020 | $51.13M | +57.9% |
| 2019 | $32.37M | -17.3% |
| 2018 | $39.13M | +240.9% |
| 2015 | $11.48M | +300.6% |
| 2014 | $-5.72M | - |